Target intelligence / Profile preview

Olfactory receptor family 1 subfamily L member 6 (OR1L6)

Target
OR1L6
Molecular classification
G protein-coupled receptor (GPCR), Receptor
01

Overview

Olfactory receptor family 1 subfamily L member 6 (OR1L6) is a protein coding gene that encodes an olfactory receptor expressed in the nasal epithelium. Like other olfactory receptors, OR1L6 is a member of the G protein-coupled receptor (GPCR) superfamily and is characterized by a seven-transmembrane domain structure essential for recognizing odorant molecules and mediating G protein-dependent signal transduction, ultimately leading to the perception of smell[3][5][7]. Olfactory receptors constitute the largest gene family in the human genome, and the nomenclature for these genes is organism-specific[3][5]. OR1L6 does not currently have established roles as a clinical biomarker or therapeutic target; no drugs targeting this receptor are approved or in clinical use[5][7]. The biological function is limited to enabling olfaction via primary signal transduction mechanisms in sensory neurons[5][7]. Reports of disease associations are limited, with rare instances such as Alternating Hemiplegia Of Childhood noted in genomic data[5]. OR1L6 and its related receptors are frequently studied for their fundamental biological roles, molecular structure, and function, particularly in understanding the mechanisms of odorant molecule recognition and GPCR signal transduction[1][7].

Other names
Olfactory receptor 1L6OR1L6OR1L7Olfactory receptor 1L7Olfactory receptor OR9-30HG16OR1K1Olfactory receptor, family 1, subfamily L, member 7
02

Mechanism of action

Activation via interaction with odorant molecules in the nose; Signal transduction mediated by G protein coupling

03

Biological functions

Signal transductionRecognition and transduction of odorant signalsInitiation of neuronal response leading to the perception of smell
04

Disease associations

Other (association reported: Alternating Hemiplegia Of Childhood)No major common disease roles described in current data
05

Safety considerations

None described; olfactory receptors are not typical therapeutic targets and do not have established safety concerns
06

Interacting drugs

None currently established for OR1L6; olfactory receptors in general can be targets for agonists/antagonists in research, but no approved drugs
07

Biomarkers

None described for OR1L6; olfactory receptors in general are not clinical biomarkers

Beyond the preview

Go deeper on Olfactory receptor family 1 subfamily L member 6 (OR1L6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 1 subfamily L member 6 (OR1L6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call